These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer. Padhani AR; Lecouvet FE; Tunariu N; Koh DM; De Keyzer F; Collins DJ; Sala E; Schlemmer HP; Petralia G; Vargas HA; Fanti S; Tombal HB; de Bono J Eur Urol; 2017 Jan; 71(1):81-92. PubMed ID: 27317091 [TBL] [Abstract][Full Text] [Related]
12. Rationale for Modernising Imaging in Advanced Prostate Cancer. Padhani AR; Lecouvet FE; Tunariu N; Koh DM; De Keyzer F; Collins DJ; Sala E; Fanti S; Vargas HA; Petralia G; Schlemmer HP; Tombal B; de Bono J Eur Urol Focus; 2017 Apr; 3(2-3):223-239. PubMed ID: 28753774 [TBL] [Abstract][Full Text] [Related]
13. The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial. Joshi A; Roberts MJ; Perera M; Williams E; Rhee H; Pryor D; Lehman M; Heathcote P; Wood S; Coucher J; Gustafson S; Miles K; Vela I Clin Exp Metastasis; 2020 Aug; 37(4):551-560. PubMed ID: 32519046 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Gauthé M; Zarca K; Aveline C; Lecouvet F; Balogova S; Cussenot O; Talbot JN; Durand-Zaleski I BMC Med Imaging; 2020 Mar; 20(1):25. PubMed ID: 32122345 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. Taylor SA; Mallett S; Beare S; Bhatnagar G; Blunt D; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Miles A; Morris S; Morton A; Navani N; O'Donohue J; Oliver A; Padhani AR; Pardoe H; Patel U; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Shahabuddin K; Sidhu HS; Teague J; Thaha MA; Train M; van Ree K; Wijeyekoon S; Halligan S; Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):529-537. PubMed ID: 31080095 [TBL] [Abstract][Full Text] [Related]
16. Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies. Taylor SA; Mallett S; Miles A; Morris S; Quinn L; Clarke CS; Beare S; Bridgewater J; Goh V; Janes S; Koh DM; Morton A; Navani N; Oliver A; Padhani A; Punwani S; Rockall A; Halligan S Health Technol Assess; 2019 Dec; 23(66):1-270. PubMed ID: 31855148 [TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084 [TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
19. The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of Metser U; Chua S; Ho B; Punwani S; Johnston E; Pouliot F; Tau N; Hawsawy A; Anconina R; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Pond G; Scott AM; Tunariu N; Sidhu H; Emmett L J Nucl Med; 2019 Sep; 60(9):1253-1258. PubMed ID: 30902875 [TBL] [Abstract][Full Text] [Related]
20. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]